Actavis Is Buying Botox-Maker Allergan for $66B
Irish pharmaceutical company Actavis will buy Allergan, the maker of Botox, for $219 per share in cash and stock, the company said in a press release...
Related Articles
- 20 Taiwan Businesspeople To Watch -- James Kuo, Austin Liu and Andy Lu also categorized in BoardNews
- Getting Gen-Y on Boards (of Directors) also categorized in BoardNews
- Germany's Corporate Governance Problem also categorized in BoardNews
- Taiwan Court Orders Reinstatement Of Two CPDC Board Candidates As Contested Vote Nears also categorized in BoardNews
- Have the Swiss Gone Cuckoo? also categorized in BoardNews
- Why Should We Care About Corporate Interlocks? also categorized in BoardNews
- TA Associates announces investment in Flashtalking also mentions Investment
- Netflix: Icahn Says Poison Pill 'Poor Corporate Governance' also categorized in BoardNews
- The Other Duty of Corporate Governance also categorized in BoardNews
- Six Years Later, The Problem at HP is Still the Board also categorized in BoardNews
Login to comment.